DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
72.83
-1.63 (-2.19%)
Nov 22, 2024, 4:00 PM EST - Market closed
DexCom Revenue
DexCom had revenue of $994.20M in the quarter ending September 30, 2024, with 1.97% growth. This brings the company's revenue in the last twelve months to $3.95B, up 16.19% year-over-year. In the year 2023, DexCom had annual revenue of $3.62B with 24.49% growth.
Revenue (ttm)
$3.95B
Revenue Growth
+16.19%
P/S Ratio
7.22
Revenue / Employee
$411,875
Employees
9,600
Market Cap
28.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.62B | 712.50M | 24.49% |
| Dec 31, 2022 | 2.91B | 461.30M | 18.84% |
| Dec 31, 2021 | 2.45B | 521.80M | 27.08% |
| Dec 31, 2020 | 1.93B | 450.70M | 30.54% |
| Dec 31, 2019 | 1.48B | 444.40M | 43.08% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cardinal Health | 224.45B |
| Centene | 146.20B |
| Koninklijke Philips | 20.12B |
| Biogen | 9.61B |
| IDEXX Laboratories | 3.84B |
| Mettler-Toledo International | 3.76B |
| BioNTech SE | 3.39B |
| West Pharmaceutical Services | 2.88B |
DXCM News
- 3 days ago - DexCom Pairs Its Glucose Monitor With Oura's Smart Ring - Barrons
- 3 days ago - Smart ring maker Ōura valued at over $5 bln after Dexcom funding - Reuters
- 3 days ago - Dexcom and ŌURA Announce Strategic Partnership - Business Wire
- 8 days ago - Dexcom Helps People With Diabetes Take the First Step to Discover What They're Made Of on World Diabetes Day - Business Wire
- 4 weeks ago - These Analysts Revise Their Forecasts On DexCom Following Q3 Results - Benzinga
- 4 weeks ago - DexCom Beats Earnings Expectations. Why the Stock Is Trading Lower. - Barrons
- 4 weeks ago - Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
- 4 weeks ago - DexCom Growing Into Its Valuation, But Still No Bargain - Seeking Alpha